Orgenesis Inc. Share Price

ORGS

US68619K3032

Medical Equipment, Supplies & Distribution

Real-time OTC Markets 07:01:51 27/05/2026 pm IST			5-day change	1st Jan Change
0.4500 ^USD	+181.25%		-32.77%	+200.00%

26/03	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/03	Orgenesis Inc. Auditor Raises 'Going Concern' Doubt	CI

Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Companyâ€™s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomeraâ€™s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
22/26/22	$0.0667	-88.69%	302
21/26/21	$0.5900	-.--%	100
18/26/18	$0.5900	+39.68%	100
17/26/17	$0.4224	-28.41%	2,838
16/26/16	$0.5900	-11.85%	100

Real-time OTC Markets

More quotes

Market Cap	10L 9L 8L 7L 13.86L 9.42Cr 13.86L 97.12L 37.48L 4.81Cr 37L 36.19L 16Cr	P/E 2023	-0.26x	P/E 2024	-0.17x
Enterprise Value	1.92Cr 1.67Cr 1.57Cr 1.44Cr 2.7Cr 183.22Cr 2.7Cr 19Cr 7.29Cr 94Cr 7.2Cr 7.04Cr 301.65Cr	EV / Sales 2023	71.2x	EV / Sales 2024	27x
Free-Float	52.06%	Yield 2023 *	-	Yield 2024	-

26/03	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/03	Orgenesis Inc. Auditor Raises 'Going Concern' Doubt	CI
26/03	Okogen, Inc. acquired Global intellectual property portfolio and development assets for ranpirnase from Orgenesis Inc..	CI
14/03	Orgenesis Inc. Announces Board Appointments, Effective March 10, 2026	CI
14/03	Orgenesis Inc. Appoints Doug Karriker as Chief Financial Officer, Effective March 10, 2026	CI
26/25/26	Orgenesis Inc. Announces Resignation of Director Ashish Nanda, Effective August 21, 2025	CI
20/25/20	Orgenesis Inc. Announces Resignation of Victor Miller as Chief Financial Officer	CI
20/25/20	Orgenesis Inc. Announces Executive and Board Changes	CI
06/25/06	Orgenesis Inc. completed the acquisition of Certain assets of Neurocords LLC for $5.7 million.	CI
22/25/22	Orgenesis Inc. announced that it expects to receive $5 million in funding	CI
28/24/28	Orgenesis Inc. Announces Resignation of Jagannathan Bhalaji as A Director	CI
13/24/13	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI
13/24/13	Orgenesis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

26/03	Orgenesis : Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)	PU
13/24/13	Orgenesis Provides Third Quarter 2024 Business Update	AQ
21/24/21	Orgenesis Commences Trading on OTCQX® Best Market	AQ
23/24/23	Orgenesis Announces Reverse Stock Split	AQ
29/24/29	Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia	AQ

1 day	+181.25%
1 week	-32.77%
Current month	+28.57%
1 month	+350.00%
3 months	-13.46%
6 months	+80.00%
Current year	+200.00%

1 week	0.07	0.59
1 month	0.03	0.79
Current year	0	0.84
1 year	0	1
3 years	0	10.8
5 years	0	52
10 years	0	168

Orgenesis Inc. Share Price

Stocks

ORGS

US68619K3032

Medical Equipment, Supplies & Distribution

Valuation: Orgenesis Inc.

Chart: Orgenesis Inc.

Latest news: Orgenesis Inc.

Press Releases: Orgenesis Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Orgenesis Inc.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Sarah Ferber CTO	Chief Tech/Sci/R&D Officer	72	02/02/2012
Vered Caplan CEO	Chief Executive Officer	57	24/12/2013
Douglas Karriker DFI	Director of Finance/CFO	51	10/03/2026

Director	Title	Age	Since
Vered Caplan CHM	Chairman	57	14/08/2014
Itzhak Vider BRD	Director/Board Member	64	08/07/2024
Adam Pelavin BRD	Director/Board Member	47	28/10/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
05/03/25	Ariel Malik	Other		12,00,000	23.2142%
12/12/24	Itzhak Vider	Free	Director	1,500	0.0290%
12/12/24	Ashish Nanda	Free	Director	1,835	0.0355%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORGENESIS INC.	+181.25%	-32.77%	+119.51%	-92.86%	7L
ABBOTT LABORATORIES	+0.35%	+1.15%	-23.81%	+6.23%	18TCr
MEDTRONIC PLC	-0.06%	-2.42%	-4.84%	+12.99%	12TCr
CENCORA, INC.	+1.70%	-0.29%	+5.02%	+69.63%	6TCr
BECTON, DICKINSON AND COMPANY	+0.67%	+0.52%	-2.00%	-31.48%	4.98TCr
HOYA CORPORATION	-0.22%	+1.23%	+7.80%	+45.79%	4.8TCr
DEXCOM, INC.	+0.26%	+2.58%	+31.36%	+4.10%	3.38TCr
MEDLINE INC.	-0.58%	+3.49%	-	-	3.02TCr
WEST PHARMACEUTICAL SERVICES, INC.	-0.13%	+2.27%	+47.62%	-1.43%	2.61TCr
SARTORIUS STEDIM BIOTECH	-0.29%	+6.14%	+9.94%	-9.26%	2.3TCr
Average	+18.28%	+1.50%	+21.18%	+0.41%	5.67TCr
Weighted average by Cap.	+0.27%	+0.44%	-3.22%	+13.65%

	2023	2024
Net sales	5L 5L 4L 4L 7L 5.07Cr 7L 52.25L 20.16L 2.59Cr 19.9L 19.47L 8.34Cr	10.35L 9L 9L 8L 14.56L 9.89Cr 14.56L 1.02Cr 39.37L 5.05Cr 38.87L 38.02L 16Cr
Net income	-5.54Cr -4.84Cr -4.55Cr -4.15Cr -7.79Cr -529.24Cr -7.79Cr -55Cr -21Cr -270.27Cr -21Cr -20Cr -871.29Cr	-4.82Cr -4.21Cr -3.96Cr -3.61Cr -6.78Cr -460.44Cr -6.78Cr -47Cr -18Cr -235.14Cr -18Cr -18Cr -758.04Cr
Net Debt	2.18Cr 1.9Cr 1.79Cr 1.63Cr 3.06Cr 208.25Cr 3.07Cr 21Cr 8.29Cr 106.35Cr 8.18Cr 8Cr 342.85Cr	1.82Cr 1.59Cr 1.49Cr 1.36Cr 2.56Cr 173.81Cr 2.56Cr 18Cr 6.92Cr 89Cr 6.83Cr 6.68Cr 286.14Cr